...
首页> 外文期刊>Cytotherapy >Utilizing regulatory T cells to control alloreactivity
【24h】

Utilizing regulatory T cells to control alloreactivity

机译:利用调节性T细胞控制同种异体反应

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Effective resetting of the immune system cannot be achieved by nonspecific immunosuppression. Instead, novel strategies aim at harnessing the body's natural tolerance mechanisms to rectify an Ag-specific response without disturbing other immune functions. Fine-tuning of the balance between Ag-specific effector and regulatory T (Tr) cells is a promising strategy that requires detailed understanding of the differentiation and expansion pathways of the relevant Tr cell subsets. Here we review recent developments regarding the control of alloreactivity by induction and expansion of Tr cells. T-cell activation in the presence of tolerogenic APC and cytokines leads to the induction of Tr cells, which can mediate tolerance through cytokine-dependent and/or contact-dependent mechanisms. Better understanding of the mechanisms of immune regulation mediated by Tr cells may enable fine-tuning of specific immune responses and pave the way for novel therapeutic approaches.
机译:通过非特异性免疫抑制不能实现免疫系统的有效复位。取而代之的是,新策略旨在利用机体的自然耐受机制来纠正Ag特异性反应,而又不干扰其他免疫功能。 Ag特异性效应子和调节性T(Tr)细胞之间的平衡的微调是一种有前途的策略,需要详细了解相关Tr细胞亚群的分化和扩增途径。在这里,我们回顾有关通过诱导和扩增Tr细胞控制同种异体反应的最新进展。在有致耐受性的APC和细胞因子的存在下T细胞的活化导致Tr细胞的诱导,这可以通过细胞因子依赖性和/或接触依赖性机制介导耐受性。更好地了解Tr细胞介导的免疫调节机制可能使特定免疫反应的微调,并为新的治疗方法铺平道路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号